RXi Pharmaceuticals completes direct public offering

RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass. Business: Inflammation, Metabolic Date completed: 3/23/10 Type: Direct public offering Raised: $16.2 million Units: 2.7 million Price: $6 (uni...